Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care
Launched by JOHNS HOPKINS UNIVERSITY · Oct 19, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people with HIV who also have mental health or substance use disorders. The goal is to see if working with a peer-case manager—someone who has experienced similar challenges—can improve care for these patients. Participants in the study will be randomly assigned to one of two groups. One group will receive the usual medical care, while the other group will get support from a peer-case manager to help them engage in treatment for their mental health or substance use issues. Everyone will complete a survey when they first join the study and then again after 12 months.
To be eligible for this study, you need to be between 18 and 99 years old, receiving HIV care at the Bartlett HIV clinic, and have been identified as needing help for a mental health or substance use disorder. You should not currently be receiving treatment for these issues, and you need to be able to speak English. This study is currently recruiting participants, and it aims to find out if this peer-supported approach can make a difference in the care provided to people living with HIV.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals 18-99 years old
- • accessing HIV care at the Bartlett HIV clinic
- • Screened positive for a Mental health disorder or substance use disorder based on a computerized self-administered screen with Patient Health Questionnaire (PHQ-9)(score\>10), General Anxiety Disorder (GAD-7) (score\>10), National Institute on Drug Abuse Drug Use Screening Tool: 3 Question Quick Screen (Response of "Yes" to one or more heavy drinking days or "Yes" to use of illegal drugs or prescription drugs for non-medical reasons.
- • Does not currently have a Mental Health or Substance Use Disorder treatment provider and or not receiving any current treatment (psychotherapy or pharmacotherapy) for Mental Health or Substance Use Disorder.
- • English speaking
- Exclusion Criteria:
- • • Individuals lacking the capacity to consent
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Oluwaseun Falade-Nwulia, MBBS, MPH
Principal Investigator
Johns Hopkins School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials